Effectiveness and safety of daptomycin versus vancomycin in methicillin-resistant staphylococci left-sided infective endocarditis: results from a nationwide prospective, multicentre cohort
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Effectiveness and safety of daptomycin versus vancomycin in methicillin-resistant staphylococci left-sided infective endocarditis: results from a nationwide prospective, multicentre cohort. // Clinical Microbiology and Infection. – URL: https://www.sciencedirect.com/science/article/pii/S1198743X26002156?dgcid=rss_sd_all
Effectiveness and safety of daptomycin versus vancomycin in methicillin-resistant staphylococci left-sided infective endocarditis: results from a nationwide prospective, multicentre cohort. Clinical Microbiology and Infection. https://www.sciencedirect.com/science/article/pii/S1198743X26002156?dgcid=rss_sd_all
“Effectiveness and safety of daptomycin versus vancomycin in methicillin-resistant staphylococci left-sided infective endocarditis: results from a nationwide prospective, multicentre cohort.” Clinical Microbiology and Infection.
@article{article41115,
title = {Effectiveness and safety of daptomycin versus vancomycin in methicillin-resistant staphylococci left-sided infective endocarditis: results from a nationwide prospective, multicentre cohort},
journal = {Clinical Microbiology and Infection},
url = {https://www.sciencedirect.com/science/article/pii/S1198743X26002156?dgcid=rss_sd_all}
}